SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-041364
Filing Date
2024-05-09
Accepted
2024-05-09 17:00:57
Documents
51
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205289-10q_oramed.htm   iXBRL 10-Q 506564
2 REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS ea020528901ex10-1_oramed.htm EX-10.1 88615
3 CERTIFICATION ea020528901ex31-1_oramed.htm EX-31.1 10051
4 CERTIFICATION ea020528901ex31-2_oramed.htm EX-31.2 9657
5 CERTIFICATION ea020528901ex32-1_oramed.htm EX-32.1 3105
6 CERTIFICATION ea020528901ex32-2_oramed.htm EX-32.2 3123
  Complete submission text file 0001213900-24-041364.txt   3266077

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ormp-20240331.xsd EX-101.SCH 31102
8 XBRL CALCULATION FILE ormp-20240331_cal.xml EX-101.CAL 34971
9 XBRL DEFINITION FILE ormp-20240331_def.xml EX-101.DEF 164122
10 XBRL LABEL FILE ormp-20240331_lab.xml EX-101.LAB 311645
11 XBRL PRESENTATION FILE ormp-20240331_pre.xml EX-101.PRE 169198
54 EXTRACTED XBRL INSTANCE DOCUMENT ea0205289-10q_oramed_htm.xml XML 243434
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 24931705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)